Related references
Note: Only part of the references are listed.Resazurin rapid screening for antibacterial activities of organic and inorganic nanoparticles: Potential, limitations and precautions
Chanthiwa Chakansin et al.
ANALYTICAL BIOCHEMISTRY (2022)
Helicobacter pylori infection: from standard to alternative treatment strategies
Claudia Sousa et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2022)
Phage therapy of wound-associated infections
Anna Zyman et al.
FOLIA MICROBIOLOGICA (2022)
The potential of bacteriophage therapy in the treatment of paediatric respiratory infections
J. D. Jones et al.
PAEDIATRIC RESPIRATORY REVIEWS (2022)
In vitro and in vivo efficacy of green synthesized AgNPs against Gram negative and Gram positive bacterial pathogens
Yequan Sheng et al.
PROCESS BIOCHEMISTRY (2022)
Phage therapy for secondary bacterial infections with COVID-19
Nannan Wu et al.
CURRENT OPINION IN VIROLOGY (2022)
Antibacterial Activity of Cerium Oxide Nanoparticles against ESKAPE Pathogens
Mushtaq A. Dar et al.
CRYSTALS (2022)
Oligonucleotide Solid Nucleolipid Nanoparticles against Antibiotic Resistance of ESBL-Producing Bacteria
Phuoc Vinh Nguyen et al.
PHARMACEUTICS (2022)
Biological foundations of successful bacteriophage therapy
Carola Venturini et al.
EMBO MOLECULAR MEDICINE (2022)
Campylobacter spp. prevalence and mitigation strategies in the broiler production chain
Jatziri Mota-Gutierrez et al.
FOOD MICROBIOLOGY (2022)
Phage Therapy in the Era of Multidrug Resistance in Bacteria: A Systematic Review
Carlos Aranaga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review
Jiaxi Lin et al.
MOLECULES (2022)
Ceftazidime-avibactam
Francisco Sanz Herrero
Revista Espanola de Quimioterapia (2022)
Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa
Peifen Chen et al.
BIOSCIENCE TRENDS (2022)
Next-Generation Approaches Needed to Tackle Antimicrobial Resistance for the Development of Novel Therapies Against the Deadly Pathogens
Vasundhra Bhandari et al.
FRONTIERS IN PHARMACOLOGY (2022)
Evaluation of Neisseria gonorrhoeae Isolates Susceptibility to Tetracycline Antibiotics from 9 Provinces in China Since 2020
Qian Zhou et al.
INFECTION AND DRUG RESISTANCE (2022)
In Vitro Activity of Cefiderocol against US and European Gram-Negative Clinical Isolates Collected in 2020 as Part of the SENTRY Antimicrobial Surveillance Program
Dee Shortridge et al.
MICROBIOLOGY SPECTRUM (2022)
Synergism between metallic nanoparticles and antibiotics
Maria Anndressa Alves Agreles et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2022)
Bacteriophage Therapy for Staphylococcus Aureus Infections: A Review of Animal Models, Treatments, and Clinical Trials
Lucile Plumet et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Battling Enteropathogenic Clostridia: Phage Therapy for Clostridioides difficile and Clostridium perfringens
Jennifer Venhorst et al.
FRONTIERS IN MICROBIOLOGY (2022)
Nanobiotics against antimicrobial resistance: harnessing the power of nanoscale materials and technologies
Nayanika Chakraborty et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Evaluation of the combined effect of antibiotics and essential oils against Campylobacter multidrug resistant strains and their biofilm formation
Aicha El Baaboua et al.
SOUTH AFRICAN JOURNAL OF BOTANY (2022)
Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital
C. Weber et al.
MICROBIOLOGY SPECTRUM (2022)
Identification of a phage-derived depolymerase specific for KL47 capsule of Klebsiella pneumoniae and its therapeutic potential in mice
Min Li et al.
VIROLOGICA SINICA (2022)
Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance
Meenal Chawla et al.
FRONTIERS IN MICROBIOLOGY (2022)
Essential Oil from Aerial Parts of Andryala pinnatifida subsp. mogadorensis: Chemical Composition, Antioxidant and Aantimicrobial Synergistic Effect Against Multidrug-Resistant Bacteria
Ouhaddou Soukaina et al.
JOURNAL OF ESSENTIAL OIL BEARING PLANTS (2022)
Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales
Marco Falcone et al.
CLINICAL INFECTIOUS DISEASES (2021)
Oral Capsulized Fecal Microbiota Transplantation for Eradication of Carbapenemase-producing Enterobacteriaceae Colonization With a Metagenomic Perspective
Haggai Bar-Yoseph et al.
CLINICAL INFECTIOUS DISEASES (2021)
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Matteo Bassetti et al.
LANCET INFECTIOUS DISEASES (2021)
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Richard G. Wunderink et al.
LANCET INFECTIOUS DISEASES (2021)
Phage therapeutics: from promises to practices and prospectives
Kanika Bhargava et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
Heterogeneous Klebsiella pneumoniae Co-infections Complicate Personalized Bacteriophage Therapy
Jinhong Qin et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics
Laura Michelle Streicher
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Methods for prevention and constraint of antimicrobial resistance: a review
Aikaterini Valsamatzi-Panagiotou et al.
ENVIRONMENTAL CHEMISTRY LETTERS (2021)
Clostridioides difficile phage biology and application
Joshua Heuler et al.
FEMS MICROBIOLOGY REVIEWS (2021)
Potential for bacteriophage therapy for Staphylococcus aureus pneumonia with influenza A coinfection
Peter G. Speck et al.
FUTURE MICROBIOLOGY (2021)
Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
Katie A. Parsels et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)
Advances in siRNA delivery strategies for the treatment of MDR cancer
Md Abdus Subhan et al.
LIFE SCIENCES (2021)
Phage-Bacteria Interactions in Potential Applications of Bacteriophage vB_EfaS-271 against Enterococcus faecalis
Gracja Topka-Bielecka et al.
VIRUSES-BASEL (2021)
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant Acinetobacter baumannii Lung Infection in a Patient With Chronic Obstructive Pulmonary Disease
Xin Tan et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection
Austen Terwilliger et al.
VIRUSES-BASEL (2021)
Efficacy and safety of eravacycline: A meta-analysis
Khalid Eljaaly et al.
Journal of Global Antimicrobial Resistance (2021)
Essential Oils in Livestock: From Health to Food Quality
Ralph Nehme et al.
ANTIOXIDANTS (2021)
The Role of Antibiotic Resistant A. baumannii in the Pathogenesis of Urinary Tract Infection and the Potential of Its Treatment with the Use of Bacteriophage Therapy
Natalia Baginska et al.
ANTIBIOTICS-BASEL (2021)
Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria
Kristen A. Eller et al.
COMMUNICATIONS BIOLOGY (2021)
Metal-based nanoparticles for combating antibiotic resistance
Esra Altun et al.
APPLIED PHYSICS REVIEWS (2021)
Nanotechnology Based Approaches in Phage Therapy: Overcoming the Pharmacological Barriers
Sandeep Kaur et al.
FRONTIERS IN PHARMACOLOGY (2021)
Preclinical data and safety assessment of phage therapy in humans
Janet Y. Nale et al.
CURRENT OPINION IN BIOTECHNOLOGY (2021)
Antibacterial activities of hexadecanoic acid methyl ester and green-synthesized silver nanoparticles against multidrug-resistant bacteria
Mohamed T. Shaaban et al.
JOURNAL OF BASIC MICROBIOLOGY (2021)
Carvacrol Essential Oil: A Natural Antibiotic against Zoonotic Multidrug-Resistant Staphylococcus Species Isolated from Diseased Livestock and Humans
Ahmed H. Abed et al.
ANTIBIOTICS-BASEL (2021)
New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives
Marco Terreni et al.
MOLECULES (2021)
Bacteriophage-mediated modulation of microbiota for diseases treatment
Yu Zhang et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
New Perspectives on Antimicrobial Agents: Cefiderocol
Erin K. McCreary et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)
Recent strategies for inhibiting multidrug-resistant and -lactamase producing bacteria: A review
Huma Fatima et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections
Yahiya Y. Syed
DRUGS (2021)
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions
Kathleen Tompkins et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Delivery of antisense oligonucleotides using multi-layer coated gold nanoparticles to methicillin-resistant S. aureus for combinatorial treatment
Marcel Janis Beha et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Alternatives to Conventional Antibiotic Therapy: Potential Therapeutic Strategies of Combating Antimicrobial-Resistance and Biofilm-Related Infections
Qian Xu et al.
MOLECULAR BIOTECHNOLOGY (2021)
Heterocyclic Chemistry Applied to the Design of N-Acyl Homoserine Lactone Analogues as Bacterial Quorum Sensing Signals Mimics
Qiang Zhang et al.
MOLECULES (2021)
vB_EfaS-DELF1, a novel Siphoviridae bacteriophage with highly effective lytic activity against vancomycin-resistant Enterococcus faecalis
Abbas Soleimani-Delfan et al.
VIRUS RESEARCH (2021)
Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects
Ifeanyi E. Mba et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2021)
Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective
Gursneh Kaur et al.
FOOD AND ENVIRONMENTAL VIROLOGY (2021)
A Case of In Situ Phage Therapy against Staphylococcus aureus in a Bone Allograft Polymicrobial Biofilm Infection: Outcomes and Phage-Antibiotic Interactions
Brieuc Van Nieuwenhuyse et al.
VIRUSES-BASEL (2021)
Bacteriophage Rescue Therapy of a Vancomycin-Resistant Enterococcus faecium Infection in a One-Year-Old Child following a Third Liver Transplantation
Kevin Paul et al.
VIRUSES-BASEL (2021)
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Antonio Moretta et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
Nanostructured Antimicrobial Peptides: Crucial Steps of Overcoming the Bottleneck for Clinics
Zhanyi Yang et al.
FRONTIERS IN MICROBIOLOGY (2021)
The Role of Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
Magdalena Stojek et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Potential for Phages in the Treatment of Bacterial Sexually Transmitted Infections
Kathryn Cater et al.
ANTIBIOTICS-BASEL (2021)
Bacteriophage Technology and Modern Medicine
Aa Haeruman Azam et al.
ANTIBIOTICS-BASEL (2021)
Gram-Positive Pneumonia: Possibilities Offered by Phage Therapy
Lucia Fernandez et al.
ANTIBIOTICS-BASEL (2021)
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review
Alex Soriano et al.
INFECTIOUS DISEASES AND THERAPY (2021)
A combination therapy of Phages and Antibiotics: Two is better than one
Xianghui Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Clostridioides difficile phage biology and application
Joshua Heuler et al.
FEMS MICROBIOLOGY REVIEWS (2021)
Ceftazidime-Avibactam To Treat Life-Threatening Infections by Carbapenem-Resistant Pathogens in Critically Ill Mechanically Ventilated Patients
Vasiliki Tsolaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Phage therapy efficacy: a review of the last 10 years of preclinical studies
Luis D. R. Melo et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2020)
Antibiotic combination therapy against resistant bacterial infections: synergy, rejuvenation and resistance reduction
Anthony R. M. Coates et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)
Activity of ceftolozane-tazobactam against Gram-negative pathogens isolated from lower respiratory tract infections in the Asia-Pacific region: SMART 2015-2016
Shu-Chen Kuo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Therapeutic bacteriophages as a rescue treatment for drug-resistant infections - an in vivo studies overview
M. Kwiatek et al.
JOURNAL OF APPLIED MICROBIOLOGY (2020)
Antimicrobial Susceptibility and Antibacterial Mechanism of Limonene against Listeria monocytogenes
Yingjie Han et al.
MOLECULES (2020)
Antimicrobial host defence peptides: functions and clinical potential
Neeloffer Mookherjee et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Evaluation of Eravacycline: A Novel Fluorocycline
Sara Alosaimy et al.
PHARMACOTHERAPY (2020)
The Future of Phage: Ethical Challenges of Using Phage Therapy to Treat Bacterial Infections
Jonathan Anomaly
PUBLIC HEALTH ETHICS (2020)
COVID-19: don't neglect antimicrobial stewardship principles!
B. D. Huttner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
COVID-19 and the potential long-term impact on antimicrobial resistance
Timothy M. Rawson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Application of phage therapy: Synergistic effect of phage EcSw (ΦEcSw) and antibiotic combination towards antibiotic-resistant Escherichia coli
Maheswaran Easwaran et al.
TRANSBOUNDARY AND EMERGING DISEASES (2020)
New and alternative strategies for the prevention, control, and treatment of antibiotic-resistant Campylobacter
Lei Dai et al.
TRANSLATIONAL RESEARCH (2020)
How covid-19 is accelerating the threat of antimicrobial resistance
Jeremy Hsu
BMJ-BRITISH MEDICAL JOURNAL (2020)
Physics in nanomedicine: Phenomena governing the in vivo performance of nanoparticles
Lucas A. Lane
APPLIED PHYSICS REVIEWS (2020)
Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales clinical isolates from US medical centres
Elizabeth B. Hirsch et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2020)
Multidrug-Resistant Bacterial Infections in US Hospitalized Patients, 2012-2017
John A. Jernigan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Antimicrobial peptides as therapeutic agents: opportunities and challenges
Margit Mahlapuu et al.
CRITICAL REVIEWS IN BIOTECHNOLOGY (2020)
Phage S144, a New Polyvalent Phage InfectingSalmonellaspp. andCronobacter sakazakii
Michela Gambino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Ruminal acidosis, bacterial changes, and lipopolysaccharides
Hugo F. Monteiro et al.
JOURNAL OF ANIMAL SCIENCE (2020)
Immunomodulatory Activities of Selected Essential Oils
Georg Sandner et al.
BIOMOLECULES (2020)
Phages for Biofilm Removal
Celia Ferriol-Gonzalez et al.
ANTIBIOTICS-BASEL (2020)
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Yuchen Huan et al.
FRONTIERS IN MICROBIOLOGY (2020)
Impact ofN-Acyl-Homoserine Lactones, Quorum Sensing Molecules, on Gut Immunity
Garance Coquant et al.
FRONTIERS IN IMMUNOLOGY (2020)
Characterization of Salmonella Isolates from Various Geographical Regions of the Caucasus and Their Susceptibility to Bacteriophages
Khatuna Makalatia et al.
VIRUSES-BASEL (2020)
Phage Therapy: Towards a Successful Clinical Trial
Andrzej Gorski et al.
ANTIBIOTICS-BASEL (2020)
Antimicrobial peptides - Advances in development of therapeutic applications
Huy Xuan Luong et al.
LIFE SCIENCES (2020)
New beta-Lactam-beta-Lactamase Inhibitor Combinations
Dafna Yahav et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Peptide based antimicrobials: Design strategies and therapeutic potential
Prakash Kishore Hazam et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2019)
Biotechnological applications of quorum sensing inhibition as novel therapeutic strategies for multidrug resistant pathogens
Mona Shaaban et al.
MICROBIAL PATHOGENESIS (2019)
Drug combinations: a strategy to extend the life of antibiotics in the 21 st century
Mike Tyers et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
James A. McKinnell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
PHAGE Study: Effects of Supplemental Bacteriophage Intake on Inflammation and Gut Microbiota in Healthy Adults
Hallie P. Febvre et al.
NUTRIENTS (2019)
Characterizing the Biology of Lytic Bacteriophage vB_EaeM_φEap-3 Infecting Multidrug-Resistant Enterobacter aerogenes
Jiangtao Zhao et al.
FRONTIERS IN MICROBIOLOGY (2019)
Reassessing the Host Defense Peptide Landscape
Evan F. Haney et al.
FRONTIERS IN CHEMISTRY (2019)
Eravacycline: The Tetracyclines Strike Back
Maria Heaney et al.
ANNALS OF PHARMACOTHERAPY (2019)
Current State of Compassionate Phage Therapy
Shawna McCallin et al.
VIRUSES-BASEL (2019)
Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections
Nicola Principi et al.
FRONTIERS IN PHARMACOLOGY (2019)
Efficacy and potential of phage therapy against multidrug resistant Shigella spp.
Swee-Seong Tang et al.
PEERJ (2019)
Lytic bacteriophages against multidrug-resistant Staphylococcus aureus, Enterococcus faecalis and Escherichia coli isolates from orthopaedic implant-associated infections
Joana Barros et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions
Michael H. Woodworth et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Eravacycline: a new treatment option for complicated intra-abdominal infections in the age of multidrug resistance
Joseph S. Solomkin et al.
FUTURE MICROBIOLOGY (2019)
Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment
Keiko Yamakawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Enhanced antibiotic activity of ampicillin conjugated to gold nanoparticles on PEGylated rosette nanotubes
Yiwen Fan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Nanoparticle-drug conjugates treating bacterial infections
Pavlina Jelinkova et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Predictive Metabolomic Signatures for Safety Assessment of Metal Oxide Nanoparticles
Li Cui et al.
ACS NANO (2019)
Cefiderocol: Discovery, Chemistry, and In Vivo Profiles of a Novel Siderophore Cephalosporin
Takafumi Sato et al.
CLINICAL INFECTIOUS DISEASES (2019)
Methicillin-Resistant Staphylococcus aureus in Hospitals: Latest Trends and Treatments Based on Bacteriophages
Andrea Alvarez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Bacterial Pathogens Isolated from Patients in Canadian Hospitals from 2013 to 2017 as Part of the CANWARD Surveillance Study
Andrew Walkty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms
Nan-Yao Lee et al.
FRONTIERS IN PHARMACOLOGY (2019)
Potential role of the antimicrobial peptide Tachyplesin III against multidrug-resistant P. aeruginosa and A. baumannii coinfection in an animal model
Jialong Qi et al.
INFECTION AND DRUG RESISTANCE (2019)
Phage Therapy in the Postantibiotic Era
Fernando L. Gordillo Altamirano et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields
Muhsin Jamal et al.
JOURNAL OF BASIC MICROBIOLOGY (2019)
Biological challenges of phage therapy and proposed solutions: a literature review
Katherine M. Caflisch et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2019)
Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial
Patrick Jault et al.
LANCET INFECTIOUS DISEASES (2019)
Cytotoxicity-Related Bioeffects Induced by Nanoparticles: The Role of Surface Chemistry
Hainan Sun et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)
Joseph L. Kuti et al.
INFECTIOUS DISEASES AND THERAPY (2019)
Exacerbations of Chronic Rhinosinusitis-Microbiology and Perspectives of Phage Therapy
Joanna Szaleniec et al.
ANTIBIOTICS-BASEL (2019)
Directed Evolution of a Mycobacteriophage
Maria Cebria-Mendoza et al.
ANTIBIOTICS-BASEL (2019)
In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from US Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Evaluation of the Bactericidal Activity of Plazomicin and Comparators against Multidrug-Resistant Enterobacteriaceae
M. Thwaites et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Evaluation of the In Vitro Activity of Eravacycline against a Broad Spectrum of Recent Clinical Anaerobic Isolates
David R. Snydman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment
Glenn E. Dale et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
In vitro activity of eravacycline against 2213 Gram-negative and 2424 Gram-positive bacterial pathogens isolated in Canadian hospital laboratories: CANWARD surveillance study 2014-2015
George G. Zhanel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Activity of plazomicin in combination with other antibiotics against multidrug-resistant Enterobacteriaceae
M. Thwaites et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Ceftolozane/tazobactam: place in therapy
Daniele Roberto Giacobbe et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2018)
Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review
Vikram Pareek et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
Bovine mastitis: An appraisal of its alternative herbal cure
Saleem Mushtaq et al.
MICROBIAL PATHOGENESIS (2018)
Antimicrobial peptides produced by Brevibacillus spp.: structure, classification and bioactivity: a mini review
Xu Yang et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2018)
Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice
Yunfen Hua et al.
FRONTIERS IN MICROBIOLOGY (2018)
Plazomicin Retains Antibiotic Activity against Most Aminoglycoside Modifying Enzymes
Georgina Cox et al.
ACS INFECTIOUS DISEASES (2018)
Bacterial antagonism in host-associated microbial communities
Leonor Garcia-Bayona et al.
SCIENCE (2018)
Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients
Omar A. Taha et al.
FRONTIERS IN MICROBIOLOGY (2018)
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Simon Portsmouth et al.
LANCET INFECTIOUS DISEASES (2018)
Complete genome analysis of a Siphoviridae phage TSK1 showing biofilm removal potential against Klebsiella pneumoniae
Rabia Tabassum et al.
SCIENTIFIC REPORTS (2018)
Advances in therapeutic bacterial antisense biotechnology
John P. Hegarty et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
In Vitro Synergism of Silver Nanoparticles with Antibiotics as an Alternative Treatment in Multiresistant Uropathogens
Montserrat Lopez-Carrizales et al.
ANTIBIOTICS-BASEL (2018)
Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration
Abrar K. Thabit et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2017)
The therapeutic applications of antimicrobial peptides (AMPs): a patent review
Hee-Kyoung Kang et al.
JOURNAL OF MICROBIOLOGY (2017)
Antibacterial and Antifungal Activities of Spices
Qing Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
Yunliang Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential
P. R. S. Lagace-Wiens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Plazomicin activity against polymyxin-resistant Enterobacteriaceae, including MCR-1-producing isolates
Valerie Denervaud-Tendon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems
Javad Sharifi-Rad et al.
MOLECULES (2017)
Differential Effect of Newly Isolated Phages Belonging to PB1-Like, phiKZ-Like and LUZ24-Like Viruses against Multi-Drug Resistant Pseudomonas aeruginosa under Varying Growth Conditions
Simone Latz et al.
VIRUSES-BASEL (2017)
Isolation and Characterization of phiLLS, a Novel Phage with Potential Biocontrol Agent against Multidrug-Resistant Escherichia coli
Luis Amarillas et al.
FRONTIERS IN MICROBIOLOGY (2017)
In Vitro Activity of Eravacycline and Comparator Antimicrobials Against 143 Strains of Bacteroides Species.
Diane Citron et al.
Open Forum Infectious Diseases (2017)
Essential Oils and Antifungal Activity
Filomena Nazzaro et al.
PHARMACEUTICALS (2017)
Phage Therapy against &ITStreptococcus pneumoniae&IT: Modern Tool to Control Pneumonia
Muhammad Imran Qadir et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2017)
Multicenter Evaluation of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Inhibitory Activity against Meropenem-Nonsusceptible Pseudomonas aeruginosa from Blood, Respiratory Tract, and Wounds
Mordechai Grupper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Safety of antisense oligonucleotide and siRNA-based therapeutics
Xuan Chi et al.
DRUG DISCOVERY TODAY (2017)
Fecal microbiota transplantation: in perspective
Shaan Gupta et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations
David van Duin et al.
CLINICAL INFECTIOUS DISEASES (2016)
Antisense antimicrobial therapeutics
Erin K. Sully et al.
CURRENT OPINION IN MICROBIOLOGY (2016)
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
George G. Zhanel et al.
DRUGS (2016)
Chemical composition, antioxidant, antibacterial and anti-quorum sensing activities of Eucalyptus globulus and Eucalyptus radiata essential oils
Angelo Luis et al.
INDUSTRIAL CROPS AND PRODUCTS (2016)
Aminoglycoside Resistance The Emergence of Acquired 16S Ribosomal RNA Methyltransferases
Yohei Doi et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Marine Antimicrobial Peptides: Nature Provides Templates for the Design of Novel Compounds against Pathogenic Bacteria
Annarita Falanga et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Current applications of nanoparticles in infectious diseases
Hinojal Zazo et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Adverse events in faecal microbiota transplant: a review of the literature
M. Baxter et al.
JOURNAL OF HOSPITAL INFECTION (2016)
Evolutionary Rationale for Phases as Complements of Antibiotics
Clara Torres-Barcelo et al.
TRENDS IN MICROBIOLOGY (2016)
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Sylvie Garneau-Tsodikova et al.
MEDCHEMCOMM (2016)
In Silico Evaluation of the Impacts of Quorum Sensing Inhibition (QSI) on Strain Competition and Development of QSI Resistance
Guopeng Wei et al.
SCIENTIFIC REPORTS (2016)
Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences
Nina Chanishvili
CURRENT DRUG DELIVERY (2016)
Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review
Amee R. Manges et al.
INFECTIOUS DISEASES (2016)
Lipid-II Independent Antimicrobial Mechanism of Nisin Depends On Its Crowding And Degree Of Oligomerization
Ashutosh Prince et al.
SCIENTIFIC REPORTS (2016)
Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives
Hyun Ho Choi et al.
CLINICAL ENDOSCOPY (2016)
Clostridium difficile Infection and Fecal Microbiota Transplant
Alyssa Liubakka et al.
AACN ADVANCED CRITICAL CARE (2016)
Ceftazidime with β-lactamase inhibitor approved for complicated infections
Cheryl A. Thompson
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Airway Epithelial Cell Integrity Protects from Cytotoxicity of Pseudomonas aeruginosa Quorum-Sensing Signals
Davide Losa et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2015)
Can Plazomicin Alone or in Combination Be a Therapeutic Option against Carbapenem-Resistant Acinetobacter baumannii?
Cristina Garcia-Salguero et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Fecal microbiota transplantation restores dysbiosis in patients with methicillin resistant Staphylococcus aureus enterocolitis
Yao Wei et al.
BMC INFECTIOUS DISEASES (2015)
Characterization of new Myoviridae bacteriophage WZ1 against multi-drug resistant (MDR) Shigella dysenteriae
Muhsin Jamal et al.
JOURNAL OF BASIC MICROBIOLOGY (2015)
Toward Repositioning Niclosamide for Antivirulence Therapy of Pseudomonas aeruginosa Lung Infections: Development of Inhalable Formulations through Nanosuspension Technology
Gabriella Costabile et al.
MOLECULAR PHARMACEUTICS (2015)
Antibacterial Activity of Essential Oils and Their Isolated Constituents against Cariogenic Bacteria: A Systematic Review
Irlan Almeida Freires et al.
MOLECULES (2015)
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Sibhghatulla Shaikh et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2015)
Loss of Vancomycin-Resistant Enterococcus Fecal Dominance in an Organ Transplant Patient With Clostridium difficile Colitis After Fecal Microbiota Transplant
Joshua Stripling et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Quorum sensing enhancement of the stress response promotes resistance to quorum quenching and prevents social cheating
Rodolfo Garcia-Contreras et al.
ISME JOURNAL (2015)
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages
Stephen T. Abedon
PHARMACEUTICALS (2015)
Gramicidin A: A New Mission for an Old Antibiotic
Justin M. David et al.
JOURNAL OF KIDNEY CANCER AND VHL (2015)
Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
Reem Almaghrabi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Plant antimicrobial peptides
Robert Nawrot et al.
FOLIA MICROBIOLOGICA (2014)
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
Xavier Wittebole et al.
VIRULENCE (2014)
The safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials
Shou Zhen Wang et al.
BMJ OPEN (2014)
The abundance of antibiotic resistance genes in human guts has correlation to the consumption of antibiotics in animal
Yongfei Hu et al.
GUT MICROBES (2014)
Nanotechnology as a therapeutic tool to combat microbial resistance
Robert Y. Pelgrift et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
New Life for an Old Drug: the Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing
Francesco Imperi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Antimicrobial Resistance and Virulence: a Successful or Deleterious Association in the Bacterial World?
Alejandro Beceiro et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Current and Potential Use of Citrus Essential Oils
Eristanna Palazzolo et al.
CURRENT ORGANIC CHEMISTRY (2013)
Phage cocktails and the future of phage therapy
Benjamin K. Chan et al.
FUTURE MICROBIOLOGY (2013)
Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model
Pieter Van den Abbeele et al.
ISME JOURNAL (2013)
The role of the natural environment in the emergence of antibiotic resistance in Gram-negative bacteria
Elizabeth M. H. Wellington et al.
LANCET INFECTIOUS DISEASES (2013)
Combined effect of a peptide-morpholino oligonucleotide conjugate and a cell-penetrating peptide as an antibiotic
Donna Wesolowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Amino acid composition of proteins reduces deleterious impact of mutations
Sahand Hormoz
SCIENTIFIC REPORTS (2013)
Infections caused by resistant Gram-negative bacilli: New molecules and combinations
V. Cattoir
JOURNAL DES ANTI-INFECTIEUX (2013)
The intestinal microbiota is the future of bacterial multidrug-resistance
E. Ruppe et al.
JOURNAL DES ANTI-INFECTIEUX (2013)
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
Mark Bounthavong et al.
Infection and Drug Resistance (2013)
Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation?
Faming Zhang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Fluorocyclines. 1. 7-Fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: A Potent, Broad Spectrum Antibacterial Agent
Xiao-Yi Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria
Maribel Guzman et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Anders Folkesson et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Pathogenesis and Pathophysiology of Pneumococcal Meningitis
Barry B. Mook-Kanamori et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Essential oils in poultry nutrition: Main effects and modes of action
A. Brenes et al.
ANIMAL FEED SCIENCE AND TECHNOLOGY (2010)
Chemical Composition and in Vitro Antimicrobial and Mutagenic Activities of Seven Lamiaceae Essential Oils
Laura De Martino et al.
MOLECULES (2009)
Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin
J. Lubelski et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Phage as an antimicrobial agent: d'Herelle's heretical theories and their role in the decline of phage prophylaxis in the West
Dottore Emiliano Fruciano et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2007)
A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs
YJ Gordon et al.
CURRENT EYE RESEARCH (2005)
Insect antimicrobial peptides: Structures, properties and gene regulation
P Bulet et al.
PROTEIN AND PEPTIDE LETTERS (2005)
Gene organization and sequences of pediocin AcH/PA-1 production operons in Pediococcus and Lactobacillus plasmids
KW Miller et al.
LETTERS IN APPLIED MICROBIOLOGY (2005)
Anti-Listeria monocytogenes activity of essential oils components of conifers
A Mourey et al.
FOOD CONTROL (2002)
Antimicrobial activity of individual and mixed fractions of dill, cilantro, coriander and eucalyptus essential oils
PJ Delaquis et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2002)
Lactation mastitis: Occurrence and medical management among 946 breastfeeding women in the United States
B Foxman et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Bactericidal antisense effects of peptide-PNA conjugates
L Good et al.
NATURE BIOTECHNOLOGY (2001)
Quorum sensing in bacteria
MB Miller et al.
ANNUAL REVIEW OF MICROBIOLOGY (2001)